1 articles with this tag
Daniella Gilboa, CEO and Co-Founder of AiVF: "This breakthrough scientific research concluded that AiVF's EMA™ platform can automatically and reliably determine an embryo's ploidy status i.e., whether it is genetically suitable, without the need for an invasive biopsy (PGT-A) or spent media analysis. A truly contactless PGT-A”